Branded

PhRMA found that in the past two years, patients with HIV, high cholesterol and diabetes whose health plans implemented value-based contracts for their medications had 28% lower out-of-pocket costs, on average, than patients in other plans.

Decadron will be available in 0.5-, 0.75-, 4- and 6-mg dosage strength tablets.

Nearly all respondents diagnosed with migraine (91%) agreed those who do not suffer from migraine do not understand the severity of the disease.

The product, which Teva said eliminates the need for hand-breath coordination, is indicated as a maintenance treatment for asthma as a prophylactic therapy in patients ages four years and older.

Wolfgang Baiker will succeed the retiring Paul Fonteyne as Boehringer Ingelheim’s U.S. president and CEO, effective March 1.

The acquisition will see Sanofi adding the Waltham, Mass.-based biopharmaceutical company's hemophilia treatments Eloctate and Alprolix to its specialty and rare disease portfolio.

ANI Pharmaceuticals has acquired four potential new drugs from AstraZeneca, the Baudette., Minn.-based company announced recently. The company acquired the new drug applications and U.S. marketing rights to Atacand, Atacand HCT, Arimidex and Casodex for $46.5 million in cash, royalties and sales-based milestones.